How Will the Critical Limb Ischemia Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the critical limb ischemia market grown over the years?
There has been robust expansion in the critical limb ischemia market size in the past few years. The market is projected to rise from a worth of $3.6 billion in 2024 to an estimated $3.9 billion in 2025, growing at a compound annual growth rate (CAGR) of 8.2%. There are several contributory factors to this growth during the historic period, including an increase in cases of diabetes, tobacco use, the prevalence of hypertension, advancements in vascular imaging techniques, increase in endovascular interventions, as well as progress in medical research and clinical trials.
What Is the forecasted market size and growth rate for the critical limb ischemia market?
The market size for critical limb ischemia is projected to experience robust expansion in the coming years, reaching $5.57 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 9.3%. Various factors contributing to the growth during the forecast period are advancements in regenerative medicine, an emphasis on preemptive measures, the rising incidence of obesity, worldwide health campaigns, and patient educational initiatives. Key trends during the anticipated period encompass wearable health tech, telemedicine alongside remote patient supervision, the utilization of artificial intelligence (AI), patient-focused care structures, and procedures that are minimally invasive.
Get your critical limb ischemia market report here!
https://www.thebusinessresearchcompany.com/report/critical-limb-ischemia-global-market-report
What are the major factors driving growth in the critical limb ischemia market?
The prevalence of diabetes mellitus and peripheral artery diseases is anticipated to boost the critical limb ischemia treatment market’s expansion in the future. Diabetes mellitus is a metabolic disorder characterized by heightened levels of glucose in the blood. Peripheral artery disease is a condition in which the arteries in the legs become narrowed, resulting in decreased blood flow to the arms or legs. These diseases raise the potential for vascular complications and limb amputations, making them risk factors for critical limb ischemia. Consequently, the increase of diabetes mellitus and peripheral artery diseases is propelling the growth of the critical limb ischemia market. For example, as of January 2022, the International Diabetes Federation predicted an expected rise of 12.2% (783.2 million people) in global diabetes prevalence by 2045. Additionally, in March 2023, the Oxford University Press journal anticipates a near 50% rise in individuals with peripheral artery disease by 2045. Thus, the increasing demand for cloud-based document processing services is fuelling the critical limb ischemia treatment market.
What key areas define the segmentation of the global critical limb ischemia Market?
The critical limb ischemia market covered in this report is segmented –
1) By Type: Devices, Drugs, Surgery
2) By Medication: Antihypertensive Agents, Antiplatelet Drugs, Antithrombotic Agents, Other Medications
3) By Application: Hospital, Clinic, Other Applications
Subsegments:
1) By Devices: Angioplasty Balloons, Stents, Catheters, Atherectomy Devices, Implantable Devices
2) By Drugs: Antiplatelet Agents, Vasodilators, Anticoagulants, Thrombolytics, Growth Factors And Cytokines
3) By Surgery: Bypass Surgery, Endarterectomy, Amputation, Revascularization Procedures
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9859&type=smp
What are the top market players propelling the growth of the critical limb ischemia industry?
Major companies operating in the critical limb ischemia market include Medtronic Plc, Boston Scientific Corporation, ThermoGenesis Holdings Inc., Abbott Laboratories, Pluri Biotech Ltd., Rexgenero Ltd., LimFlow SA, Micro Medical Solutions, Cardiovascular Systems Inc., Cynata Therapeutics Ltd, Shanghai MicroPort Medical (Group) Co Ltd., B. Braun SE, Teva Pharmaceutical Industries Ltd., Aldagen Inc., Cook Medical, Philips, BD, Penumbra Inc., Cardinal Health Inc., Teleflex Incorporated, AngioDynamics Inc., Endologix Inc., Terumo Corporation, Teleflex, MicroPort Scientific, Silk Road Medical, LeMaitre Vascular Inc., Merit Medical Systems Inc., Shockwave Medical, Avinger, Biomerics LLC, Intact Vascular Inc., Soundbite Medical Solutions, Bluegrass Vascular Technologies, PQ Bypass, Vasorum Ltd, Rex Medical, Otsuka Medical Devices, Aortica Corporation
What are the key trends shaping the future of the critical limb ischemia market?
In the critical limb ischemia (CLI) treatment market, leading corporations are driving advancement by introducing innovative products with cutting-edge technology, such as dissolving stents. These products aim to enhance the treatment results of this extreme type of peripheral artery disease. Generally known as bioresorbable stents, these dissolving stents serve as temporary support to the concerned artery, slowly dissolving once the vessel has recuperated. For example, Abbott Laboratories, a medical device firm based in the US, secured approval in April 2024 from the Food and Drug Administration (FDA), a federal agency in the United States, for its Esprit BTK Everolimus Eluting Resorbable Scaffold System. This specific dissolving stent, aimed at patients with chronic limb-threatening ischemia (CLTI) affecting arteries below the knee, marks a first-ever approval for this type of stent in the US. This stent, made from materials that are similar to dissolving sutures, is engineered to dissolve gradually over an estimated three-year period post-implantation. It emits the immunosuppressive medication everolimus, which aids in preventing artery re-narrowing and promotes healing of the vessel.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9859
What regions are dominating the critical limb ischemia market growth?
North America was the largest region in the critical limb ischemia treatment market in 2024. The regions covered in the critical limb ischemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
3D Cell Culture Technologies Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report
Catalyst Fertilizer Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/catalyst-fertilizer-global-market-report
Electronic and Precision Equipment Repair and Maintenance Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
